About Hui Tian
Form D filings for Topo Therapeutics in 2024 list Hui Tian as executive officer and director.
Hui Tian first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Hui Tian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Hui Tian works with at each company, as listed on that company's latest Form D.
Topo Therapeutics, Inc. · Form D/A, Dec 31, 2024
BB
Bruce Bean
Director
MM
Madgalene Moran
Chief Executive Officer and director
KK
Karin Kleinhans
Director
JJ
James Goater, Jr.
Director